Table 3.
Outcomes | Unstandardized Beta (95% Cl) |
Uncorrected p | Holm-Bonferroni Corrected p |
---|---|---|---|
eGFR | −10.36 (−17.50, −3.22) | 0.01 | 0.05* |
SUA | 0.29 (0.09, 0.50) | 0.01 | 0.05* |
ACRa | 0.08 (−0.04, 0.19) | 0.20 | >0.99 |
BUN | −1.29 (−1.87, −0.70) | <0.001 | <0.001* |
ALT a | 0.03 (−0.02, 0.08) | 0.27 | >0.99 |
ALPa, b | 0.00 (−0.01, 0.01) | 0.95 | >0.99 |
AST a | 0.00 (−0.04, 0.04) | >0.99 | >0.99 |
Serum albumin | −0.03 (−0.09, 0.03) | 0.29 | >0.99 |
GGT | −0.71 (−1.92, 0.50) | 0.24 | >0.99 |
Note. Regression analyses were adjusted for age, sex, race, body mass index, ratio of family income to poverty and daily protein intake. Sampling weights were applied to these regression analyses; N=25,930,302; unweighted n = 1983; MEC weights were re-weighted to our dietary sample for regression analyses;
Plasma fluoride exposure and outcome variables were log2 transformed;
Model included a quadratic term;
Significant at p ≤ 0.05 after Holm-Bonferroni correction; Regression results remained consistent regardless of whether MEC weights or re-weighted MEC weights were applied.